Ad-hoc

NEW YORK (NY), May 23, 2020  – Royalty Pharma plc today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to its proposed initial public offering of its Class A ordinary shares.

NEW YORK (NY), February 28, 2020  – Royalty Pharma announced today that Chris Hite has agreed to join the Company as Executive Vice President and Vice Chairman. Chris joined Citi as Global Head of Healthcare Investment Banking in 2008 and most recently served as Vice Chairman and Global Head of

NEW YORK – January 28, 2020 –  Royalty Pharma, the largest acquiror of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, announced today that George Grofik has been appointed Senior Vice President, Head of Investor Relations and Communications.

New York, NY (US) – September 7, 2011  – Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully refinanced $2.75 billion of outstanding debt and funded a one-time $850 million cash distribution to